High Quality Content by WIKIPEDIA articles! L-733,060 is a drug developed by Merck, Sharpe & Dohme which acts as an orally active, non-peptide, selective antagonist for the NK1 receptor, binding with a Ki of 0.08nM. Only one enantiomer is active which has made it the subject of several asymmetric synthesis efforts.